Morgan Stanley Lifts Nucor Rating to Outperform With $310 Price Target

Morgan Stanley upgraded Nucor (NUE) to Outperform with a $310 price target, citing its balance sheet and production gains. Shares rose 0.5% Tuesday. UBS also upgraded NUE to Buy with a $307 target.

Original reporting
Published Nov 18, 2026, 9:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Lifts Nucor Rating to Outperform With $310 Price Target — source image
Decision brief

The 30-second read

$NUEBullishMed
01

Why it matters

The rating change could trigger short covering and new buying interest.

02

Market read

Analyst upgrade provides a fresh catalyst for Nucor, offering a short‑term trading edge.

03

What to watch

Potential headwinds from global steel overcapacity and input cost volatility.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Morgan Stanley cited Nucor's strong balance sheet and production gains as reasons for the upgrade.

Company-level read

Ticker impact

$NUEBullishHigh confidence
Context

Morgan Stanley upgraded Nucor to Outperform and raised the price target to $310, the first report of this rating change.

Expected impact

likely modest upside as investors price in the upgraded rating and higher target

Evidence & confidence

The upgrade and $310 target are new information that can prompt buying pressure.

Market effects

May lift sentiment for the broader U.S. steel sector.

Potentially supports industrial stocks in the U.S. market.

Limited to investors tracking steel and materials equities.

Counterpoint

Some investors may view the upgrade as premature given cyclical steel demand.

Key entities

  • Morgan Stanley

    Upgraded Nucor to Outperform with a $310 price target.

Related articles

$NUEMed

Morgan Stanley upgrades Nucor stock rating on capital spending outlook

Morgan Stanley upgraded Nucor (NYSE:NUE) to Overweight, raising its price target to $310. The firm cited Nucor's capital spending outlook, compelling valuation, and strong returns. Morgan Stanley forecasts declining capital expenditures and increasing free cash flow. Nucor's third-quarter 2026 EPS was $5.80, exceeding guidance. Several other analysts also upgraded Nucor's rating and raised price targets.